Bone Health in Facioscapulohumeral Muscular Dystrophy

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.94 enrolled

Overview

This is a cross-sectional single visit study to determine bone health in individuals with FSHD.

Bone health will be assessed using 1) a DEXA scan to measure bone mineral density and lean body mass, and 2) blood tests of biomarkers of bone resorption and formation. These procedures will be correlated to measures of muscle strength testing and timed function tests to determine fracture risk in FSHD individuals considering age, gender, muscle strength and FSHD allele size.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Facioscapulohumeral Muscular Dystrophy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Genetic diagnosis of FSHD including chromosome 4 deletion and haplotype * Age \> 18 years * Ability to provide written informed consent for participation in the study * Ability to participate in the DEXA scan Exclusion Criteria: * Unwillingness or inability to comply with the requirements of this protocol (in the opinion of the PI) including, but not limited to, the presence of any condition (physical, mental or social) that precludes the participant from comfortably and safely obtaining a DEXA scan, phlebotomy, or neurological examination

Locations (2)

Kennedy Krieger Institute, Johns Hopkins School of Medicine

Baltimore, Maryland, United States

Concord Hospital Neurology Department, Hospital Road, Concord NSW 2139

Sydney, Australia

Outcomes

Primary Outcomes

Bone Mineral Density in FSHD

To determine if bone mineral density is reduced in individuals with FSHD compared to normative data of individuals of the same age and gender without FSHD.The Bone Mineral Density Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean of a reference population (i.e., healthy, age and sex-matched individuals). Negative numbers indicate values lower than the reference population and positive numbers indicate values higher than the reference population

Time frame: Single visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.